magnolol has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JH; Hsu, FT; Kuan, LY; Su, CM; Weng, YS | 1 |
Chung, HJ; Kang, YJ; Lee, MA; Lee, SK; Min, HY; Park, EJ; Park, HJ; Shin, Y | 1 |
2 other study(ies) available for magnolol and Colorectal Neoplasms
Article | Year |
---|---|
Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Disease Progression; Humans; Lignans; Male; Mice, Inbred BALB C; Mitochondria; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Receptors, Death Domain; Signal Transduction | 2020 |
Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Colorectal Neoplasms; Female; HCT116 Cells; HEK293 Cells; Humans; Lignans; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Wnt3A Protein; Xenograft Model Antitumor Assays | 2012 |